AAV-CYP46A1 is beneficial in Alzheimer's disease: from mice to non-human primates

被引：0

作者：

Alves, S. ^{[7
]}

Michaelsen-Preusse, K. ^{[6
]}

Audrain, M. ^{[1
,2
,3
]}

Aron-Badin, R. ^{[4
]}

Lamaziere, A. ^{[5
]}

Rey, E. ^{[1
,2
,3
]}

Fol, R. ^{[1
,2
,3
]}

Braudeau, J. ^{[1
,2
,3
]}

Despres, G. ^{[5
]}

Fouquet, F. ^{[1
,2
,3
]}

Korte, M. ^{[6
]}

Hantraye, P. ^{[4
]}

Aubourg, P. ^{[1
,2
,3
]}

Cartier, N. ^{[1
,2
,3
]}

机构：

[1] INSERM, U1169, Le Kremlin Bicetre, France

[2] MIRCen CEA, F-91400 Orsay, France

[3] Univ Paris Saclay, Univ Paris Sud, F-91400 Orsay, France

[4] MIRCen, I2BM, DSV, CEA, F-92265 Fontenay Aux Roses, France

[5] Sorbonne Univ, Pierre & Marie Curie Paris6, Lab Mass Spectrometry,CNRS,LBM, INSERM,ERL 1157,UMR 7203, Paris, France

[6] TU Braunschweig, Inst Zool, Div Cellular Neurobiol, Brunswick, ME USA

[7] Brainvectis Therapeut, F-92265 Fontenay Aux Roses, France

来源：

HUMAN GENE THERAPY | 2017年 / 28卷 / 12期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

P221

引用

页码：A77 / A77

页数：1

共 50 条

[21] Virulence of oral Fusobacterium nucleatum from humans and non-human primates in mice [J].

Gaetti-Jardim, E ;

Luvizotto, MCR ;

Avila-Campos, MJ .

BRAZILIAN JOURNAL OF MICROBIOLOGY, 2000, 31 (02) :146-150

[22] A chemical approach for global protein knockdown from mice to non-human primates [J].

Xiuyun Sun ;

Jun Wang ;

Xia Yao ;

Wen Zheng ;

Yang Mao ;

Tianlong Lan ;

Liguo Wang ;

Yonghui Sun ;

Xinyi Zhang ;

Qiuye Zhao ;

Jianguo Zhao ;

Rui-Ping Xiao ;

Xiuqin Zhang ;

Guangju Ji ;

Yu Rao .

Cell Discovery, 5

[23] A chemical approach for global protein knockdown from mice to non-human primates [J].

Sun, Xiuyun ;

Wang, Jun ;

Yao, Xia ;

Zheng, Wen ;

Mao, Yang ;

Lan, Tianlong ;

Wang, Liguo ;

Sun, Yonghui ;

Zhang, Xinyi ;

Zao, Qiuye ;

Zhao, Jianguo ;

Xiao, Rui-Ping ;

Zhang, Xiuqin ;

Ji, Guangju ;

Rao, Yu .

CELL DISCOVERY, 2019, 5 (1)

[24] Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study [J].

Jester, Hannah M. ;

Gosrani, Saahj P. ;

Ding, Huiping ;

Zhou, Xueyan ;

Ko, Mei-Chuan ;

Ma, Tao .

JOURNAL OF ALZHEIMERS DISEASE, 2022, 88 (03) :957-970

[25] AAV-mediated CYP46A1 gene therapy for Huntington's disease [J].

Cartier, N. ;

Alves, S. ;

Christaller, W. ;

Subashi, E. ;

Kacher, R. ;

Lamaziere, A. ;

Despres, G. ;

Saudou, F. ;

Caboche, J. ;

Betuing, S. .

HUMAN GENE THERAPY, 2017, 28 (12) :A3-A3

[26] Quantitative Analysis of Subretinal AAV-GFP in Fluorescent Fundoscopy Images from Non-Human Primates [J].

Newmark, Judith A. ;

Timmers, Adrian M. ;

Song, Chunjuan ;

Lie, Guo-Jie ;

Shearman, Mark S. .

MOLECULAR THERAPY, 2018, 26 (05) :48-48

[27] Successful repeated hepatic gene delivery in mice and non-human primates achieved by sequential administration of AAV2/5 and AAV1 vector serotypes [J].

Majowicz, Anna ;

Salas, David ;

Aseguinolaza, Gloria Gonzalez ;

Petry, Harald ;

Ferreira, Valerie .

HUMAN GENE THERAPY, 2014, 25 (11) :A53-A53

[28] Shedding light on gene therapy of Parkinson's disease in non-human primates [J].

Yan, Xunyi ;

Jin, Xin .

INNOVATION, 2024, 5 (02)

[29] AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice [J].

Liguore, William A. ;

Domire, Jacqueline S. ;

Button, Dana ;

Wang, Yun ;

Dufour, Brett D. ;

Srinivasan, Sathya ;

McBride, Jodi L. .

MOLECULAR THERAPY, 2019, 27 (11) :2018-2037

[30] Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates [J].

Collier, Timothy J. ;

Kanaan, Nicholas M. ;

Kordower, Jeffrey H. .

NATURE REVIEWS NEUROSCIENCE, 2011, 12 (06) :359-366

← 1 2 3 4 5 →